Scandinavian ChemoTech
1.25
SEK
+13.64 %
Less than 1K followers
CMOTEC B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
+13.64%
+12.61%
-30.17%
-11.97%
-44.2%
-42.44%
-90.35%
-76.96%
-96.68%
Scandinavian ChemoTech is a research and development company that has developed the technology Tumor-Specific Electroporation - TSE ™ for the treatment of various cancers. The technology means that electronic pulses are sent to the treated area and the membranes of the tumor cells are opened to reach their DNA. In addition to its operations in Sweden, the company is also active in Southeast Asia and India. Scandinavian ChemoTech was founded in 2015 and is headquartered in Lund.
Read moreMarket cap
29.18M SEK
Turnover
8.02K SEK
Revenue
6.57M
EBIT %
-194.82 %
P/E
-
Dividend yield-%
-
Financial calendar
6.5
2025
Interim report Q1'25
13.5
2025
General meeting '25
12.8
2025
Interim report Q2'25
All
Press releases
ShowingAll content types
Scandinavian ChemoTech AB (publ) publishes Year-End Report January - December 2024
Scandinavian ChemoTech Restructures Loans and Doubles the Duration to 12 Months
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools